Burcon Nutrascience Corporation (BU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 133 | 682 | 511 | 303 | 178 |
| Accounts receivable | -103 | 158 | -413 | -91 | 282 |
| Other Working Capital | -357 | -205 | -1,283 | 291 | -356 |
| Other Operating Activity | -1,246 | -2,599 | -1,492 | -1,521 | -1,560 |
| Operating Cash Flow | $-1,574 | $-1,964 | $-2,677 | $-1,018 | $-1,456 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -129 | -521 | -148 | -88 | -14 |
| Other Investing Activity | -17 | -16 | 43 | -1,405 | 5 |
| Investing Cash Flow | $-146 | $-538 | $-105 | $-1,492 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 215 | N/A |
| Debt Repayment | -8 | -8 | -6 | -219 | -6 |
| Other Financing Activity | 1,263 | 0 | -79 | 9,197 | 1,008 |
| Financing Cash Flow | $1,255 | $-8 | $-85 | $9,193 | $1,003 |
| Exchange Rate Effect | -2 | 31 | -178 | 2 | 16 |
| Beginning Cash Position | 1,754 | 4,232 | 7,276 | 591 | 1,037 |
| End Cash Position | 1,287 | 1,754 | 4,232 | 7,276 | 591 |
| Net Cash Flow | $-464 | $-2,509 | $-2,866 | $6,683 | $-462 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,574 | -1,964 | -2,677 | -1,018 | -1,456 |
| Capital Expenditure | -129 | -521 | -148 | -88 | -14 |
| Free Cash Flow | -1,703 | -2,485 | -2,825 | -1,106 | -1,470 |